KEVIN DENLINGER: Open Payments
NPI 1487638300 · HOUGHTON LAKE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 24 payments from 12 companies in 2025. Trend: 2023 $368 · 2024 $624 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 2 | $125 |
| Lilly USA, LLC | 4 | $71 |
| Novartis Pharmaceuticals Corporation | 4 | $71 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| ABBVIE INC. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| PFIZER INC. | 1 | $25 |
| Amgen Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
Products named: VOQUEZNA, MOUNJARO, LEQVIO, TRELEGY ELLIPTA, VRAYLAR, CAPLYTA, AIRSUPRA, NURTEC ODT.
Industry payments across MI — which companies pay providers there.
